Metraipolis › archive › dc_f6ecc04ea478

Stem cell therapies to modulate harmful immune responses in kidney disease: progress toward clinical validation — Europe PMC PMID:41903207

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41903207
DOI
10.1093/stmcls/sxag015
License (as archived)
solo-consultazione
Archived
2026-11-02T22:58:47.894Z
SHA-256 of the archived text
a62179b7a7ff37966554be44a26d7876be366a0917208c27aabd290a693f8a83
Stable URL of this page
https://metraipolis.com/documento/dc_f6ecc04ea478

How to cite

Stem cell therapies to modulate harmful immune responses in kidney disease: progress toward clinical validation — Europe PMC PMID:41903207 — Europe PMC (en), https://europepmc.org/article/MED/41903207 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f6ecc04ea478 (Metraipolis archive dc_f6ecc04ea478, sha256 a62179b7a7ff37966554be44a26d7876be366a0917208c27aabd290a693f8a83)
BibTeX
@misc{dcf6ecc04ea478,
  title = {Stem cell therapies to modulate harmful immune responses in kidney disease: progress toward clinical validation — Europe PMC PMID:41903207},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41903207},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f6ecc04ea478; sha256 a62179b7a7ff37966554be44a26d7876be366a0917208c27aabd290a693f8a83},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41903207. Agents can read the archived copy with the MCP tool read_document.